ACE-031 vs Ipamorelin

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

ACE-031 and Ipamorelin are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares ACE-031 and Ipamorelin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

ACE-031Ipamorelin
CategoryPerformance & GrowthPerformance & Growth
Regulatory status (US)Research use onlyResearch use only
Typical dosageResearch only200-300 mcg
Frequencyresearchtwice-daily
Reported benefitsSignificant muscle growth, strength gainsNatural GH release, improved body composition, better sleep, anti-aging effects, no appetite increase
Reported side effectsResearch compound, not for human useVery well-tolerated. Rare: headache, injection site reactions

Key differences

Primary use. ACE-031 is categorised under Performance & Growth, while Ipamorelin falls under Performance & Growth. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. ACE-031: not FDA-approved; treated as a research compound. Ipamorelin: not FDA-approved; treated as a research compound.

Dosing. ACE-031 is typically dosed at Research only (research). Ipamorelin is typically dosed at 200-300 mcg (twice-daily).

Can you stack them?

Some protocols combine peptides, but stacking ACE-031 and Ipamorelin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between ACE-031 and Ipamorelin?
ACE-031 and Ipamorelin are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status. ACE-031 is not FDA-approved; generally classified as a research compound, whereas Ipamorelin is not FDA-approved; generally classified as a research compound.
What is ACE-031 used for?
Myostatin inhibitor.
What is Ipamorelin used for?
GH secretagogue, anti-aging.
Can you take ACE-031 and Ipamorelin together?
Some users combine peptides within a single protocol, but stacking ACE-031 and Ipamorelin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is ACE-031 or Ipamorelin FDA-approved?
ACE-031 is not FDA-approved; generally classified as a research compound. Ipamorelin is not FDA-approved; generally classified as a research compound.

Read the full articles

  • ACE-031 — full monograph: mechanism, research, dosing & references
  • Ipamorelin — full monograph: mechanism, research, dosing & references

More Performance & Growth comparisons

← All peptide comparisons